Induction of GLI2 activator (GLI2ΔN) in mice promotes the development of BCC-like tumors whose clinico-pathologic type depends on the cell of origin, tissue context (quiescent versus growing hair follicles), and level of oncogenic signals. This evidence concerns the gene GLI2 and skin basal cell carcinoma.